???global.info.a_carregar???
Identification

Personal identification

Full name
Maria Inês Veiga de Almeida Barros

Citation names

  • Barros, Inês
  • Barros, Maria Inês

Author identifiers

Ciência ID
181E-7AB3-4734
ORCID iD
0000-0002-3893-6416

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Neurosciences
  • Medical and Health Sciences - Medical Biotechnology - Technologies Involving the Manipulation of Cells, Tissues, Organs or the Whole Organism
  • Natural sciences - Biological Sciences - Biochemistry
  • Natural sciences - Biological Sciences - Molecular Biology

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Intermediate (B1) Advanced (C1)
Portuguese (Mother tongue)
Education
Degree Classification
2019 - 2023
Ongoing
PhD Programme in Experimental Biology and Biomedicine (Doutoramento)
Major in Biotechnology and Health
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
2019
Concluded
Master in Pharmaceutical Biotechnology (Mestrado)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Assessing the putative role of mesenchymal stromal cells’ effectors in Machado-Joseph disease " (THESIS/DISSERTATION)
18
2013 - 2016
Concluded
Degree in Biochemistry (Licenciatura)
Major in Biochemistry
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Diabetic retinopathy and GLP-1-based " (THESIS/DISSERTATION)
17
Affiliation

Others

Category
Host institution
Employer
2019 - Current PhD student. Project: From mesenchymal stromal cells to its secretome: Clarifying the mechanism of alleviation of Machado-Jos; supervised by: Luís Almeida, PhD; Catarina Miranda, PhD Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
2017/05/22 - 2019/03/04 Master's Degree student. Project: Assessing the putative role of mesenchymal stromal cells ’effectors in Machado-Joseph disease; supervised by: Luís Almeida, PhD; Catarina Miranda, PhD CNC.IBILI, Portugal
Universidade de Coimbra Faculdade de Farmácia, Portugal
2016/02/01 - 2016/06/01 Undergraduate student; Project: diabetic retinopathy and therapies based on glucagon-like peptide-1 hormone (GLP-1); supervised by: Rosa Fernades, PhD CNC.IBILI, Portugal
Outputs

Publications

Conference abstract
  1. Gonçalves, Andreia; Barros, Inês; J Martins; C A. Gomes; C. Fontes-Ribeiro; Ambrósio, António Francisco; Fernades, Rosa. "Exendin-4, a glucagon-like peptide 1 analog, prevents the increase in blood-retinal barrier permeability and microglia activation in a type 1 diabetes animal model". Paper presented in Glia, 2017.
    Published
Conference poster
  1. Barros, Inês; Silva, António; Martins, Inês; Duarte, Sónia; Nobre, Rui Jorge; Simões, Ana Teresa; de Almeida, Luís Pereira; Miranda, Catarina Oliveira. "Therapeutic effects of Mesenchymal Stromal Cells Secretome in Machado-Joseph Disease Models.". Paper presented in XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  2. Barros, Inês; Martins, Inês; Duarte, Sónia; Nobre, Rui Jorge; Simões, Ana Teresa; Gomes, Célia; Oliveira Miranda, Catarina; Pereira de Almeida, Luís. "Assessing the putative role of mesenchymal stromal cells' effectors in Machado-Joseph disease". Paper presented in 1st Annual meeting in Pharmaceutical Sciences in Coimbra, Portugal, 2019.
  3. Costa, L.; Barros, Inês; Gonçalves, A.; Gomes, Célia; Fontes-Ribeiro, C.; Ambrósio, António Francisco; Fernandes, Rosa. "The glucagon-like peptide 1 receptor agonist Exendin-4 prevents diabetes-induced retinal vascular dysfunction and microglia activation". Paper presented in III Symposium of the Portuguese Glial Network, Porto, 2018.
  4. Fernandes, Rosa; Gonçalves, Andreia; Barros, Inês; Costa, L.; Gomes, Célia; Ambrósio, António Francisco. "O agonista do receptor do GLP-1, exendina-4, previne o aumento da permeabilidade da barreira hemato-retiniana e a ativação das células da micróglia num modelo animal de diabetes do tipo 1". Paper presented in 14º Congresso Português de Diabetes, Vilamoura, 2018.
  5. Gonçalves, Andreia; Barros, Inês; Martins, J.; Gomes, Célia; Fontes-Ribeiro, C.; Ambrósio, António Francisco; Fernandes, Rosa. "Exendin-4, a glucagon-like peptides 1 analog, prevents the increase in blood-retinal barrier permeability and microglia activation in a type 1 diabetes animal model.". Paper presented in XIII European Meeting on Glial Cells in Health and Disease, 2017.
Journal article
  1. Ana S. Neto; Patrícia Pereira; Ana C. Fonseca; Carla Dias; Mariana C. Almeida; Inês Barros; Catarina O. Miranda; et al. "Highly Porous Composite Scaffolds Endowed with Antibacterial Activity for Multifunctional Grafts in Bone Repair". Polymers (2021): https://doi.org/10.3390/polym13244378.
    10.3390/polym13244378
  2. Barros, Inês; Silva, António; de Almeida, Luís Pereira; Miranda, Catarina Oliveira. "Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy". Cytokine & Growth Factor Reviews (2020): http://dx.doi.org/10.1016/j.cytogfr.2020.12.002.
    Published • 10.1016/j.cytogfr.2020.12.002
  3. Barros, Inês; Marcelo, Adriana; Silva, Teresa P.; Barata, João; Rufino-Ramos, David; Pereira de Almeida, Luís; Miranda, Catarina O.. "Mesenchymal Stromal Cells' Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?". Frontiers in Cellular Neuroscience 14 (2020): http://dx.doi.org/10.3389/fncel.2020.584277.
    Published • 10.3389/fncel.2020.584277
  4. Oliveira Miranda, Catarina; Marcelo, Adriana; Silva, Teresa Pereira; Barata, João; Vasconcelos-Ferreira, Ana; Pereira, Dina; Nóbrega, Clévio; et al. "Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease". Molecular Therapy 26 9 (2018): 2131-2151. http://dx.doi.org/10.1016/j.ymthe.2018.07.007.
    10.1016/j.ymthe.2018.07.007
Thesis / Dissertation
  1. Barros, Inês. "Assessing the putative role of mesenchymal stromal cells’ effectors in Machado-Joseph disease". Master, Universidade de Coimbra Faculdade de Farmácia, 2019.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2022/02/09 Assessing The Potential Of Mesenchymal Stromal Cells For Alleviation Of Blood-Brain Barrier Dysfunction In Machado-Joseph Disease 52ª reunião da Sociedade Portuguesa de Farmacologia - SPF 2022
Sociedade Portuguesa de Farmacologia (Porto)
2019/12/19 MSC Success in Promoting Ameliorations in Machado-Joseph Disease - Where do We Stand and Where We Should Go? Center for Innovative Biomedicine and Biotechnology (CIIB) Meeting
Center for Innovative Biomedicine and Biotechnology (Coimbra, Portugal)
2019/10/10 Spectroscopic Biomarkers as a Way of Monitoring MSC Success in Promoting Neuropathological and Phenotypic Ameliorations in Machado-Joseph Disease Models 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
Portuguese Society for Stem Cells and Cell Therapies (Lisboa, Portugal)
2019/05/22 Repeated transplantation of mesenchymal stromal cells in Machado-Joseph Disease/Spinocerebelar ataxia type-3 can sustainably alleviate phenotypic symptoms and ameliorations can be monitored through magnetic resonance spectroscopy 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (Coimbra, Portugal)
Distinctions

Award

2016 Prémio 3% dos Melhores Estudantes / 3% Best Students Award
Universidade de Coimbra, Portugal